Medication info

Empagliflozin 25 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Light yellow, oval-shaped, film-coated tablets with a biconvex surface
Packaging
10 tablets/box [10 tablets/PTP*1], 30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle
Approval status
Active

MFDS item code 202102105 · Approved 2021.03.05

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in regulating blood glucose in patients with type 2 diabetes
View approved original text

This medication is used to assist in blood glucose control in adults with type 2 diabetes. Initially, it can be administered alone in conjunction with dietary and exercise therapy. If sufficient blood glucose control is not achievable with monotherapy, it may be used in combination with metformin or other antidiabetic medications. Especially when blood glucose control is not adequately achieved with existing therapies, it can be used alongside medications such as insulin or DPP-4 inhibitors. This medication also helps with blood glucose control in patients with type 2 diabetes who have cardiovascular disease. Overall, this medication is effectively used for blood glucose management and complication prevention in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Precautions

This medication should not be administered to certain patients. First, it should not be used if the patient is allergic to any components of this medication. Additionally, it should not be taken by patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired renal function, specifically those with a glomerular filtration rate of less than 30 mL/min/1.73m2 or those undergoing dialysis due to end-stage kidney disease should not use this medication. Since this medication contains lactose, patients with lactose intolerance or hereditary lactose metabolism disorders should not be administered this medication. Cautious use is required for patients with slightly impaired renal function. Patients with a glomerular filtration rate of less than 60 mL/min/1.73m2 should not use this medication from the start, and those currently receiving it may need to reduce their dosage or discontinue it. There is no expected effect in patients with end-stage renal disease or those undergoing dialysis. Patients with heart failure, particularly those with mild to moderate severity, should use this medication with caution, while it is not recommended for those with severe heart failure. Taking this medication alongside insulin or sulfonylureas may increase the risk of hypoglycemia, so a reduction in the dosage of insulin or those agents may be necessary. Patients should be vigilant for adverse reactions while taking this medication. The most common adverse reaction is hypoglycemia, which occurs more frequently when used in combination with insulin or sulfonylureas. Symptoms such as genital infections, urinary tract infections, and increased urination may arise; in such cases, patients should consult their doctor. Dehydration or hypotension due to decreased fluid volume may also occur, so elderly patients or those with low blood pressure should exercise caution. This medication may rarely cause severe infections like necrotizing fasciitis, so immediate treatment is required if related symptoms (such as pain, swelling, and redness) arise. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, the medication should be discontinued. Children under 18 years have not established safety and efficacy for this medication, thus it should not be administered to them. There have been no reports of specific toxic reactions with overdose, but appropriate therapeutic measures are necessary according to the clinical condition. This medication should be kept out of reach of children and should not be transferred to other containers. Due to the risk of hypoglycemia, caution should be taken when driving or operating machinery. While monitoring blood glucose control, this medication may affect the results of the 1,5-AG test, so it is better to use other methods.

Side effects

  • Hypoglycemia
  • ketoacidosis
  • vulvar lichen planus
  • balanitis
  • other genital infections
  • urinary tract infections
  • perineal necrosis
  • itching
  • rash
  • urticaria
Show 220 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • traction retinal detachment
  • extremity injury
  • road traffic accident
  • splenic injury
  • sternal fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • upper abdominal pain
  • cavities
  • erosive gastritis
  • abdominal discomfort
  • gastroesophageal reflux disease
  • abdominal distension
  • anal bleeding
  • chronic gastritis
  • enteritis
  • bloating
  • gastric polyps
  • gingival swelling
  • hematochezia
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea capitis
  • dental abscess
  • nasopharyngitis
  • herpes zoster
  • orthostatic dizziness
  • sensory loss
  • perceptual disturbances
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • tenderness at the puncture site
  • weight gain
  • ECG abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • reduced appetite
  • obesity
  • hyperphagia
  • hyperlipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • extremity pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • ocular discomfort
  • conjunctival hyperemia
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin lacerations
  • contusions
  • rib fractures
  • concussion
  • corneal abrasion
  • falls
  • hand fractures
  • iliotibial band syndrome
  • open globe injury
  • pelvic fractures
  • palpitations
  • tachycardia
  • atherosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • hepatitis
  • otalgia
  • orthostatic vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • constipation
  • dizziness
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, oval-shaped, film-coated tablets with a biconvex surface

Package unit

10 tablets/box [10 tablets/PTP*1], 30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.